New shot for high blood pressure shows promise in japanese study
NCT ID NCT06423352
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called zilebesiran in 36 Japanese adults with mild to moderate high blood pressure. The goal was to see if it is safe and helps lower blood pressure over 6 months. Participants received either the drug or a placebo, and researchers monitored side effects and blood pressure changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TO MODERATE HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Trial Site
Fukuoka, Japan
-
Clinical Trial Site
Osaka, Japan
-
Clinical Trial Site
Tokyo, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.